Medicines containing active substance CX-024414 (single-stranded, 5’-capped messenger RNA (mRNA) produced using a cell-free in vitro transcription from the corresponding DNA templates, encoding the viral spike (S) protein of SARS-CoV-2)
This site has the patient leaflet or the SPC of 1 medicine with the active substance CX-024414 (single-stranded, 5’-capped messenger RNA (mRNA) produced using a cell-free in vitro transcription from the corresponding DNA templates, encoding the viral spike (S) protein of SARS-CoV-2).
- 1 CX-024414 (single-stranded, 5’-capped messenger RNA (mRNA) produced using a cell-free in vitro transcription from the corresponding DNA templates, encoding the viral spike (S) protein of SARS-CoV-2) only
Medicines containing only CX-024414 (single-stranded, 5’-capped messenger RNA (mRNA) produced using a cell-free in vitro transcription from the corresponding DNA templates, encoding the viral spike (S) protein of SARS-CoV-2)
| Medicine | Legal category |
|---|---|
| Spikevax (previously COVID-19 Vaccine Moderna) SPC | – |
Sources: the MHRA product information and the European Medicines Agency (patient leaflets and SPCs), the NHS Dictionary of Medicines and Devices (dm+d), NHS Business Services Authority (substances, ATC codes and legal categories). Contains public sector information licensed under the Open Government Licence v3.0. Ask your doctor or pharmacist which medicine is right for you.